What are the differences between a 30 mg dose of sucrosomial iron (30 mg elemental iron) and ferrous sulfate tablets containing 65 mg elemental iron?

Comparison of Sucrosomial Iron 30 mg vs Ferrous Sulfate 65 mg Elemental Iron

Ferrous sulfate 65 mg elemental iron remains the first-line, guideline-recommended oral iron therapy due to its proven efficacy and low cost, while sucrosomial iron 30 mg offers a better-tolerated alternative with comparable effectiveness for patients who cannot tolerate traditional iron salts. 1

Key Differences

Elemental Iron Content & Dosing

• Ferrous sulfate: Standard 200 mg tablet contains 65 mg elemental iron 2
• Sucrosomial iron: Each tablet contains 30 mg elemental iron 1
• The ferrous sulfate dose delivers more than twice the elemental iron per tablet

Absorption Mechanism

Sucrosomial iron has a fundamentally different absorption pathway compared to ferrous sulfate:

• Ferrous sulfate: Absorbed as ionic iron through enterocytes via standard iron transport mechanisms, which triggers hepcidin elevation for up to 48 hours, blocking subsequent absorption 3, 1
• Sucrosomial iron: Ferric pyrophosphate encased in a phospholipid-sucrose matrix that is absorbed as intact particles through both enterocytes and M cells via paracellular and transcellular routes 4, 5

This structural difference means sucrosomial iron bypasses the hepcidin-mediated absorption block that limits ferrous sulfate effectiveness 4.

Gastrointestinal Tolerability

The most clinically significant difference lies in side effect profiles:

Ferrous sulfate causes GI adverse effects in the majority of patients 1:

• Constipation: 12%
• Diarrhea: 8%
• Nausea: 11%
• Meta-analyses show 2.32-fold higher odds of GI side effects vs placebo 1
• Real-world discontinuation rates reach up to 40% in observational studies 1

Sucrosomial iron demonstrates markedly superior GI tolerance:

• In celiac disease patients intolerant to ferrous sulfate, sucrosomial iron showed lower severity of abdominal pain, bloating, and constipation 6
• GI side effects comparable to placebo in clinical trials 1
• Does not induce inflammatory markers (IL-6, CRP, SAA1) unlike ferrous sulfate 4

Clinical Efficacy

Both formulations effectively treat iron deficiency anemia, but with different kinetics:

Ferrous sulfate 65 mg:

• More rapid initial response in the first week 4
• Guideline-recommended dose is 50-100 mg elemental iron once daily 1
• Should increase hemoglobin by 1 g/dL within 2 weeks 3
• Requires 2-3 months continuation after Hb normalization to replete stores 1

Sucrosomial iron 30 mg:

• Licensed dose is 30 mg twice daily (60 mg total elemental iron/day) 1
• More effective iron repletion in the second week of treatment 4
• In celiac disease patients, showed +10.1% Hb increase at 90 days (vs +16.2% for ferrous sulfate 105 mg), with no statistical difference between groups 6
• Recent comparative study showed significantly higher improvement in Hb and ferritin levels vs conventional iron salts 7
• Slower rate of iron loading but maintained tolerance over one year, normalizing Hb in 89% of cases 1

Cost Considerations

This is a critical practical difference:

• Ferrous sulfate: £1.00 per 28 days 1
• Sucrosomial iron: £47.60 per 28 days (at licensed 30 mg twice daily dosing) 1

Sucrosomial iron costs approximately 48 times more than ferrous sulfate but remains considerably less expensive than IV iron formulations 1.

Clinical Decision Algorithm

Start with ferrous sulfate 65 mg once daily (one 200 mg tablet) taken on empty stomach 1:

• This is the guideline-recommended first-line approach
• Most cost-effective option
• Proven efficacy across decades of use

Switch to sucrosomial iron 30 mg twice daily if:

• Patient develops intolerable GI side effects with ferrous sulfate
• Patient has inflammatory bowel disease (particularly inactive IBD where GI tolerance is crucial) 1
• Patient has celiac disease with known ferrous sulfate intolerance 6
• Previous documented failure of traditional iron salts 1
• Moderate anemia (Hb >95 g/L) where slower iron loading is acceptable 1

Consider IV iron instead if:

• Severe anemia with circulatory compromise
• Malabsorption conditions (active IBD, post-bariatric surgery)
• Iron loss exceeds oral absorption capacity
• Failed response to oral iron after 4 weeks (Hb should increase by 1 g/dL within 2 weeks) 3

Important Caveats

Hepcidin effect: Taking ferrous sulfate more than once daily provides no additional benefit due to hepcidin-mediated absorption blockade lasting 48 hours 3, 1. Alternate-day dosing may improve tolerance with similar absorption 1.

Dietary interactions: Both formulations absorb better on empty stomach. Taking with 500 mg vitamin C improves absorption even with calcium/fiber present 3. Avoid tea/coffee within 1 hour of iron intake 3.

Monitoring: Check Hb at 4 weeks to confirm response, then continue iron for 2-3 months after Hb normalization to replete stores 1.

Inflammatory response: Ferrous sulfate induces hepcidin and inflammatory markers (IL-6, CRP) while sucrosomial iron does not 4, which may be particularly relevant in patients with underlying inflammatory conditions.

The evidence shows that while ferrous sulfate 65 mg delivers more elemental iron per dose and costs dramatically less, sucrosomial iron 30 mg (dosed twice daily for 60 mg total) offers a legitimate alternative for the substantial proportion of patients who cannot tolerate traditional iron salts, with comparable long-term efficacy and superior GI tolerance 6, 5, 7.